Botwood Nicholas A.J.

Officer at SNDX

Sold, on record
$1.2M
Dollars the filings state
Form 4 sales
1
Latest Jun 12, 2026
Form 144 notices
2
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • SNDXSyndax Pharmaceuticals IncOfficer

Sales by reason

1
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 144 notice SNDXNotice
    Jun 11, 2026 2026

    Filed to sell 34,280 shares ($609k)

    Botwood Nicholas A.J., Officer

    10b5-1 planFirst sale on recordFiling

  2. 2 Form 144 notice SNDXNotice
    Jun 12, 2026 +1 day

    Filed to sell 31,235 shares ($567k)

    Botwood Nicholas A.J., Officer

    10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 sale SNDXRoutine
    Jun 12, 2026 same day

    Sold 65,515 shares at $18.07 ($1.2M)

    Botwood Nicholas A.J., Head of R&D, CMO

    10b5-1 planSold 51.8% of holdings ($2.3M position)60,885 shares leftFirst sale on recordFollows a Form 144Filing

Every transaction

Loading transactions…

Sales and notices (3)

Form 144 notices and Form 4 sales by Botwood Nicholas A.J.
Source
Jun 12, 2026Jun 12, 2026SNDXHead of R&D, CMOForm 4 sale65,515$1.2M51.8%RoutineSEC
Jun 12, 2026Jun 12, 2026SNDXOfficerForm 144 notice31,235$567kNoticeSEC
Jun 11, 2026Jun 11, 2026SNDXOfficerForm 144 notice34,280$609kNoticeSEC